ArticleCell & bioscience2018

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Fei Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.